October 6, 2026/
VigiFlow tips and tricks, including the rationale for coding both drug and reaction, handling dosing intervals and durations, using trade names and active ingredients effectively, leveraging...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
VigiFlow tips and tricks, including the rationale for coding both drug and reaction, handling dosing intervals and durations, using trade names and active ingredients effectively, leveraging...
New Legal Provisions on Subcontracting, Strengthened Risk-Based Inspection Cycles, and Updated Regulatory Framework for EU Pharmacovigilance Oversight
Terminology updates, Standardised MedDRA Query (SMQ) modifications, the reversal of medication error term classifications, new translations, and LLT currency status changes.
